Michael Saylor Predicts The Bitcoin Reserve

Saylor says Trump may buy 1 million BTC with his reserve announcement.

You're receiving this email because you're subscribed to Future Finance from Benzinga. To manage your subscription, click the link at the bottom of this email.


Gm and Happy Thursday!

A Bitcoin reserve with 1 million BTC purchased by the U.S. government? Michael Saylor thinks that’s what Donald Trump may announce tomorrow.

MSTR shorts are reducing their positions, but is that bullish for the stock? Here’s what technical analysis says.

Plus, the Whisper Index uncovers stocks on the verge of major moves—before the mainstream catches on. It’s how we spotted Insmed, Sprouts and Uber before their 20%+ gains. This week’s new picks drop Friday—will you see them first or hear about them later?

TOP STORY

Could the U.S. really buy 1 million Bitcoin in order to create a crypto reserve?

Michael Saylor says yes.

“The Lummis bill has laid out the idea of acquiring Bitcoin strategically over four years, just consistently day by day, in order to reach a million Bitcoin target,” he said in an interview with Fox Business.

How would that work, and is it really going to happen?

SPECIAL OFFER

The Whisper Index uncovers stocks on the verge of major moves—before the mainstream catches on. It’s how we spotted Insmed, Sprouts and Uber before their 20%+ gains. This week’s new picks drop Friday—will you see them first or hear about them later?

QUICK N DIRTY

Fartcoin is not part of the proposed crypto reserve (yet), but it’s still benefiting from the anticipation building — it’s up 16% today.

XRP is another crypto doing well off the back of the reserve announcement — it’s up 16% as well (over the past week).

Vladimir Putin is getting along well with Donald Trump, but that doesn’t mean he will follow Trump’s lead on a potential crypto reserve — here’s why Russia is rejecting it.

FINTECH FOCUS

The short interest on Strategy’s stock (formerly MicroStrategy) decreased during the last reporting period, falling from 24.01 million to 22.92 million shares.

Despite a reduction in the number of shorts, the technical indicators painted a mixed picture for the stock. As the stock closed at $308.55 apiece on Wednesday, it was clearly in a long-term uptrend, as it’s above its 200-day moving average of $234.93.

So, what does the future hold for MSTR?

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this daily newsletter delivers top stories, fast movers and hot trade ideas straight to your inbox. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis and news. Subscribe here.

Tech Trends: Get the inside scoop on AI, the hottest gadgets and mind-blowing tech trends. Subscribe here.

Disclaimer: This communication from Benzinga is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of Benzinga. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. Investors should consider their investment objectives and risks before investing. Benzinga is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.